Abstract
An article published in this journal used a randomized controlled trial to evaluate the efficacy of combining chloroquine/hydroxychloroquine (CQ/HCQ) and zinc in the treatment of COVID-19 patients. Findings from this study indicate that zinc supplements did not enhance the clinical efficacy of hydroxychloroquine in improving COVID-19 treatment. Although this finding is consistent with many previous studies, several concerns regarding study protocol and trial registration, including interventions and primary outcomes, have been raised in which the protocol has been changed after the completion of the recruitment.
Similar content being viewed by others
Data Availability
Data sharing is not applicable to this article.
References
Abd-Elsalam S, Soliman S, Esmail ES et al (2021) Do zinc supplements enhance the clinical efficacy of hydroxychloroquine?: a randomized, multicenter trial. Biol Trace Elem Res 199(10):3642–3646. https://doi.org/10.1007/s12011-020-02512-1
Thomas S, Patel D, Bittel B et al (2021) Effect of high-dose zinc and ascorbic acid supplementation vs usual care on symptom length and reduction among ambulatory patients with SARS-CoV-2 infection: the COVID A to Z randomized clinical trial. JAMA Netw Open 4(2):e210369
Horby P, Mafham M, Linsell L et al (2020) Effect of hydroxychloroquine in hospitalized patients with Covid-19. N Engl J Med 383(21):2030–2040
Krleza-Jerić K, Chan AW, Dickersin K et al (2005) Principles for international registration of protocol information and results from human trials of health related interventions: Ottawa statement (part 1). BMJ 330(7497):956–958
Zinc with chloroquine/hydroxychloroquine in treatment of COVID-19. https://ClinicalTrials.gov/show/NCT04447534. Accessed 3 Mar 2023
Author information
Authors and Affiliations
Contributions
DS and KHH drafted the manuscript. All the authors read and approved the final manuscript.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Ethics Approval Statement
N/A
Patient Consent Statement
N/A
Permission to Reproduce Material from Other Sources
N/A
Clinical trial registration
N/A
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Sornsil, D., Harada, K.H. & Phosri, A. History of Changes in the Protocol of Clinical Trial of Zinc Supplementation in Treatment of COVID-19 by Hydroxychloroquine. Biol Trace Elem Res 202, 1926–1927 (2024). https://doi.org/10.1007/s12011-023-03807-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12011-023-03807-9